VIRMA not only regulates tumor-associated proliferation and metastasis factors but also participates in the activation of classical oncogenic signaling pathways, such as STAT3 and PI3K/AKT, which are crucial for cancer proliferation and metastasis. The gene discussed is AKT1; the disease is cancer.